PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 61 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 490 | +3.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 474 | -92.8% | 0.00% | – |
| Q2 2022 | $12,000 | +500.0% | 6,588 | +808.7% | 0.00% | – |
| Q4 2021 | $2,000 | -98.7% | 725 | -98.2% | 0.00% | – |
| Q3 2021 | $157,000 | +0.6% | 40,858 | 0.0% | 0.00% | – |
| Q2 2021 | $156,000 | +2128.6% | 40,858 | +1089.1% | 0.00% | – |
| Q3 2020 | $7,000 | – | 3,436 | +1105.6% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 285 | -98.0% | 0.00% | – |
| Q3 2019 | $49,000 | +4800.0% | 14,382 | +3829.5% | 0.00% | – |
| Q2 2019 | $1,000 | – | 366 | +815.0% | 0.00% | – |
| Q1 2018 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |